Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleoporin 35 (NUP35) is a member of the nucleoporin family, localized to the nuclear rim as a core structural component of the nuclear pore complex (NPC), which regulates molecular trafficking between the nucleus and cytoplasm in eukaryotic cells[1][3][4][5][6]. NUP35 has two membrane binding regions and interacts with other nucleoporins and nuclear transport factors as part of NPC architecture[5][6]. In addition to its essential nuclear transport roles, NUP35 is dynamically involved in cell cycle progression and has specialized functions in spindle assembly and chromosome alignment during oocyte meiosis, likely in a regulated (phosphorylated) form[2]. There is no evidence that NUP35 is a direct therapeutic target or that drugs specifically modulate its activity, and it is not associated with established clinical biomarkers or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleoporin 35 (NUP35).